Aptus Pharma Limited has submitted a regulatory filing to BSE Limited regarding the upload of its earnings call recording. The disclosure is made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
The company conducted an earnings call on October 26, 2026, which covered financial results and performance for the half year ended September 30, 2026. This filing serves as confirmation that the audio recording of this earnings call has been uploaded to the company's official website at https://aptus-pharma.com/concall-aptus-pharma-ltd/.
The filing references a previous intimation made to the exchange on October 21, 2026, regarding the earnings call. The document is signed by Tejash Hathi, Managing Director of Aptus Pharma Limited, with DIN 03151221. The digital signature timestamp shows the document was signed on October 26, 2026, at 18:57:29 IST.
The filing is addressed to The BSE Ltd at Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400001, and requests that the information be taken on record.